Novartis Consumer Health issues voluntary recall of certain OTCs sold in the United States

BASEL, Switzerland — Following the recent voluntary suspension of operations and shipments from its Lincoln, Neb.-based facility, Novartis Consumer Health announced a voluntary recall of some of its over-the-counter products sold in the United States.

The company said it is voluntarily recalling all lots of select bottle packaging configurations from retailers of Excedrin and NoDoz products with expiration dates of Dec. 20, 2014 or earlier, in addition to Bufferin and Gas-X Prevention products with expiration dates of Dec. 20, 2013 or earlier.

The voluntary recall is precautionary, the company said, and follows consumer complaints of chipped and broken pills and inconsistent bottle packaging. There have been no related adverse events reported with the issues leading to the recall, the company noted.

Information on the affected bottle sizes, and related expiration dates will be available at NovartisOTC.com.

Novartis Consumer Health's parent company, Novartis Group, said it is fully committed to ensure the quality, safety and integrity of its products.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.